RhumbLine Advisers’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $411K | Buy |
|
|||||
|
2025
Q2 | $297K | Buy |
|
|||||
|
2025
Q1 | $434K | Sell |
|
|||||
|
2024
Q4 | $390K | Buy |
|
|||||
|
2024
Q3 | $416K | Buy |
|
|||||
|
2024
Q2 | $255K | Buy |
|
|||||
|
2024
Q1 | $210K | Buy |
|
|||||
|
2023
Q4 | $217K | Sell |
|
|||||
|
2023
Q3 | $418K | Buy |
|
|||||
|
2023
Q2 | $499K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $212K | Buy |
|
|||||
|
2021
Q4 | $170K | Sell |
|
|||||
|
2021
Q3 | $382K | Buy |
|
|||||
|
2021
Q2 | $471K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $76K | Hold |
|
|||||
|
2019
Q4 | $179K | Buy |
|
|||||
|
2019
Q3 | $161K | Buy |
|
|||||
|
2019
Q2 | $180K | Buy |
|
|||||
|
2019
Q1 | $245K | Buy |
|
|||||
|
2018
Q4 | $192K | Buy |
|
|||||
|
2018
Q3 | $192K | Sell |
|
|||||
|
2018
Q2 | $113K | Buy |
|